We hypothesize that while PN shares some immune features with AD, such as Th2 responses, its more complex pathology involving Th17 and Th22 pathways may lead to SERPINB3/4 expression being regulated by cytokines like IL‐22, independent of atopic history. This evidence concerns the gene IL22 and Alzheimer disease.